219 related articles for article (PubMed ID: 14666639)
1. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of papillary thyroid carcinoma: uni- and multivariate analysis of prognostic factors (TNM staging system included).
Pelizzo MR; Toniato A; Grigoletto R
J Exp Clin Cancer Res; 1997 Sep; 16(3):261-5. PubMed ID: 9387899
[TBL] [Abstract][Full Text] [Related]
5. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example.
Brierley JD; Panzarella T; Tsang RW; Gospodarowicz MK; O'Sullivan B
Cancer; 1997 Jun; 79(12):2414-23. PubMed ID: 9191532
[TBL] [Abstract][Full Text] [Related]
6. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
7. Predictors of outcome in patients with papillary thyroid carcinoma.
Kjellman P; Zedenius J; Lundell G; Bäckdahl M; Farnebo LO; Hamberger B; Larsson C; Wallin G
Eur J Surg Oncol; 2006 Apr; 32(3):345-52. PubMed ID: 16459050
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system.
Salvesen H; Njølstad PR; Akslen LA; Albrektsen G; Søreide O; Varhaug JE
Eur J Surg; 1992; 158(11-12):583-9. PubMed ID: 1363062
[TBL] [Abstract][Full Text] [Related]
9. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
Marchesi M; Biffoni M; Biancari F; Berni A; Campana FP
Eur J Surg Suppl; 2003 Jul; (588):46-50. PubMed ID: 15200043
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of AMES scoring system in selection of extent of surgery in well differentiated carcinoma of thyroid.
Van Nguyen K; Dilawari RA
Am Surg; 1995 Feb; 61(2):151-5. PubMed ID: 7856976
[TBL] [Abstract][Full Text] [Related]
11. Association between different variants of papillary thyroid carcinoma and risk-group according to AMES (age, metastasis, extent and size) classification system.
Keelawat S; Poumsuk U
J Med Assoc Thai; 2006 Apr; 89(4):484-9. PubMed ID: 16696394
[TBL] [Abstract][Full Text] [Related]
12. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
13. [Differentiated thyroid cancer--staging and prognostic systems].
Dănilă R; Andriescu L; Grigorovici A; Dragomir C; Găluşcă B; Vulpoi C; Ungureanu C; Mogoş V
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):71-6. PubMed ID: 16607831
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors determining survival in differentiated thyroid cancer.
Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
[TBL] [Abstract][Full Text] [Related]
16. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
17. Prognostic scoring systems in differentiated thyroid carcinoma: which is the best?
Kingma G; van den Bergen HA; de Vries JE
Neth J Surg; 1991 Jun; 43(3):63-6. PubMed ID: 1922882
[TBL] [Abstract][Full Text] [Related]
18. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
20. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
